News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News AHA 2023 Coincidental Nonischemic Cardiomyopathy Impacts Prognosis in CAD Todd Neale November 09, 2023
News Conference News AHA 2023 Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients Caitlin E. Cox November 07, 2023
News Conference News TCT 2023 Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI Yael L. Maxwell November 06, 2023
News Conference News TCT 2023 Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis Todd Neale November 02, 2023
News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions L.A. McKeown October 31, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Conference News TCT 2023 VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli L.A. McKeown October 27, 2023
News Conference News TCT 2023 ‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II Michael O'Riordan October 26, 2023
News Conference News TCT 2023 CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER Todd Neale October 26, 2023
News Conference News TCT 2023 TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER Yael L. Maxwell October 26, 2023
News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News TCT 2023 Comparing DCBs in De Novo CAD: Drugs, Design Matter Caitlin E. Cox October 25, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Conference News TCT 2023 More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact Yael L. Maxwell October 24, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Conference News TCT 2023 OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions Todd Neale October 23, 2023